BlackRock Group LTD - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2016$76,000
-14.6%
4,299
+15.2%
0.00%
Q3 2016$89,000
+58.9%
3,732
+7.1%
0.00%
Q2 2016$56,000
-24.3%
3,486
-2.3%
0.00%
Q1 2016$74,000
+60.9%
3,568
+110.0%
0.00%
Q4 2015$46,0001,6990.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2016
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders